{"nct_id":"NCT01718158","title":"Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy","status":"COMPLETED","status_verified_date":"2015-09","start_date":"2013-01","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}